Cranio-facial dysmorphism: experimental study in the mouse, clinical applications

Area of Science:

• Developmental Biology
• Teratology
• Craniofacial Biology

Background:

• Mandibulo-facial dysostosis and hemicraniofacial microsomia are complex human congenital conditions.
• Understanding the etiology of these conditions is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the teratogenic effects of retinoic acid (RA) and methyl-triazene (Methyl) on craniofacial development in mouse embryos.
• To compare induced malformations with human mandibulo-facial dysostosis and hemicraniofacial microsomia.

Main Methods:

• Histologic and scanning electron microscope analysis of mouse embryos exposed to RA or Methyl during gestation.
• Dose-dependent administration of 13 cis-retinoic acid (400 mg/kg) on day 9.
• Administration of methyl-triazene (1.5 mg) on day 10.5.

Main Results:

• Retinoic acid exposure resulted in anomalies resembling human mandibulo-facial dysostosis, including branchial arch hypoplasia (79%), auricular anomalies (47%), and ophthalmic anomalies (12.5%).
• Methyl-triazene induced significant micromandibles and ear anomalies (94.6%-100%) in embryos.
• No correlation was established between methyl-triazene administration and hemicraniofacial microsomia.

Conclusions:

• Retinoic acid is a potent teratogen causing craniofacial malformations similar to mandibulo-facial dysostosis in mice.
• Methyl-triazene induces distinct craniofacial defects, primarily affecting the mandible and ears, but is not linked to hemicraniofacial microsomia.
• This study provides insights into the developmental pathways of craniofacial anomalies and potential etiological factors.